• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 2017

View Archived Issues

FDA clears IND for phase II study of 177Lu-PSMA-617

Read More

Lupin identifies new PARP-1 inhibitors

Read More

Ono Pharmaceutical recaps milestones of third quarter of fiscal 2016

Read More

Clinical improvement in ADHD seen with fasoracetam in phase I trial, phase II/III study underway

Read More

AstraZeneca reviews milestones of fourth quarter 2016

Read More

Phase II trial results of RG-7667 for CMV infection prevention in kidney transplant recipients

Read More

HIF1-alpha identified as a target for relapsing triple-negative breast cancer

Read More

Longevity Biotech and UNMC awarded continuing grant for the development of LBT-3627

Read More

GW Pharmaceuticals reports topline results from phase II study of THC:CBD in glioblastoma

Read More

Nanjing Hairong, Nanjing Heron patent loxoprofen derivatives

Read More

FDA approves Parsabiv to treat secondary hyperparathyroidism in patients on hemodialysis

Read More

Amgen reflects on achievements of fourth quarter 2016

Read More

Sunshine Lake Pharma discloses 5-HT reuptake inhibitors/5-HT1A receptor agonists

Read More

Targeting zinc finger protein SNAI1 induces apoptosis in bladder cancer cells

Read More

Vyome Biosciences announces promising results for VB-1953

Read More

Marina Biotech signs licensing agreement for SMARTICLES platform

Read More

Flexion Therapeutics' Zilretta NDA accepted for review by FDA

Read More

FDA awards fast track designation to Angionetics' Generx

Read More

Investigator-sponsored phase I trial of Actinium Pharmaceuticals' Actimab-M begins

Read More

Buparlisib shows promise in patients with platinum-pretreated recurrent head and neck carcinoma

Read More

Acticor Biotech raises funds to advance lead candidate

Read More

GeNeuro, NINDS enter agreement regarding antibodies for ALS

Read More

Series B financing at Prexton Therapeutics to support phase II trials of foliglurax

Read More

Cancer Research Technology, Tusk Therapeutics and UCL collaborate on cancer immunotherapies

Read More

Popular Stories

  • Telomeres and DNA illustration

    23andme founder-led group outbids Regeneron for company

    BioWorld
    The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2025.
  • Sarepta signage

    Elevidys’ second liver death hits Sarepta, sends DMD ripples

    BioWorld
    How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 18, 2025.
  • 3D representation of tumor microenvironment

    EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment

    BioWorld Science
    Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe